A tweet by José Ramón Cabañas, director of the Center for International Policy Research, reported that 11 cities in the United States have requested, through their councils, to establish medical cooperation with Cuba, based on their achievements in the fight against COVID-19. 19.
History records the interest in that exchange. In 2015, at the Global Diabetic Foot Conference, which takes place in Hollywood, Jorge Berlanga, Doctor of Science, creator of Heberprot-P, confirmed that "the knowledge and prestige of the Cuban medicine is growing. There are a number of medical professionals in the US willing to try it out, recognizing it as a possible alternative to reduce the number of amputations performed there, which are over 70,000 a year."
Closer in time, in 2021, the Roswell Park Institute, based in New York, announced the start of a clinical study with the Cuban CIMAVAX-EGF vaccine in the prevention of lung cancer. The research seeks to treat smokers who are at high risk of developing lung cancer, as well as patients with cancer in early stages, who are at risk of recurring the disease.
Based on the results in the two countries, researchers from the Center for Molecular Immunology and Roswell Park are exploring its use to prevent lung cancer.
Nor is Cuba's willingness to provide medical services to the United States new. In 2005, a brigade of professionals specialized in natural disasters and major epidemics offered to assist the victims of Hurricane Katrina.
Yesterday, on Universal Health Coverage Day, José A. Portal Miranda, Minister of Public Health of Cuba, expressed that "we ratify our willingness to share the experiences achieved with other peoples, as a way of contributing to the scope of health coverage universal for all, a policy that can provide a greater level of equity in the world.